News
1d
Investor's Business Daily on MSNNovo Nordisk Just Leapfrogged Eli Lilly With A Weight-Loss Pill; Shares PopNovo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.
The White House has responded to Elon Musk's harsh criticism of Donald Trump's economic advisor, Peter Navarro, downplaying the feud as a disagreement between individuals with differing views on ...
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co. (PG), Novo Nordisk A/S (NVO) and PepsiCo, Inc. (PEP), as well as two micro-cap stocks ...
WASHINGTON — The White House will no longer respond to reporters who list their preferred gender pronouns in their email signatures because they “ignore scientific realities.” “It is ...
It has been a tough period for Novo Nordisk shareholders. In the summer of 2024 ... military attack,” he said at a press conference in Copenhagen.“There is no direct […] The EU will delay its response ...
BT: How does Novo Nordisk view competition in the obesity treatment space? VS: Obesity is a complex chronic disease affecting millions globally. Tackling it requires a collective effort — no ...
April 3 to April 8: The president, White House officials, congressional Republicans and their allies insist there is simply no way that Trump would back down under pressure as his tariff policy ...
The Tennessee Volunteers football Orange and White Spring Game will be held at ... at noon on the Vol Village stage following Vol Walk. No ticket is required for Vol Village, and it closes at ...
Top White House trade adviser Peter Navarro on Monday “guaranteed” that the US will not plunge into a recession under President Trump and claimed there would be no inflation despite ongoing ...
Since The White Lotus considers itself to be a true acting ensemble, none of its main stars campaign in the lead categories at the Emmys. Instead, they all compete in supporting, where it's a true ...
SAO PAULO (Reuters) - Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results